
ETNB
89bio Inc.
$14.87
$0.00(0.00%)
20
Overall
--
Value
20
Tech
--
Quality
Market Cap
$1.08B
Volume
14.37M
52W Range
$4.16 - $15.06
Target Price
$29.00
Order:
Income Statement
Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|
OPERATING EXPENSES | ||||||||
Operating Expenses | $26.6M | $49.4M | $89.7M | $102.2M | $151.2M | $384.7M | ||
Research & Development | $21.3M | $36.2M | $70.3M | $80.8M | $122.2M | $345.0M | ||
Research Expense | $21.3M | $36.2M | $70.3M | $80.8M | $122.2M | $345.0M | ||
Selling, General & Administrative | $5.3M | $13.2M | $19.4M | $21.5M | $29.0M | $39.6M | ||
General & Administrative Expenses | $5.3M | $13.2M | $19.4M | $21.5M | $29.0M | $39.6M | ||
Salaries & Wages | $-389.0K | -- | -- | $10.4M | $16.1M | $20.6M | ||
Depreciation & Amortization | $-17.0K | $60.0K | -- | -- | -- | -- | ||
Depreciation & Amortization | $-17.0K | $60.0K | -- | -- | -- | -- | ||
Other Operating Expenses | -- | -- | $-557.0K | $-752.0K | $-1.2M | $-3.0M | ||
OPERATING INCOME | ||||||||
Operating income | $-26.6M | $-49.4M | $-89.7M | $-102.2M | $-151.2M | $-384.7M | ||
EBITDA | $-57.2M | $-49.3M | $-89.5M | $-99.1M | $-132.4M | $-359.5M | ||
NON-OPERATING ITEMS | ||||||||
Interest Expense (Non-Operating) | -- | -- | $674.0K | $1.9M | $4.8M | $5.3M | ||
Intinc | -- | -- | $148.0K | $2.2M | -- | -- | ||
Net Non-Operating Interest Income/Expense | -- | -- | $-526.0K | $-242.0K | $-4.8M | $-5.3M | ||
Other Income/Expense | $30.6M | $203.0K | $-219.0K | $-2.2M | $-17.7M | $-23.6M | ||
Other Special Charges | $-30.6M | $-203.0K | $219.0K | $2.2M | $17.7M | $23.6M | ||
PRE-TAX INCOME | ||||||||
EBIT | $-57.2M | $-49.4M | $-89.6M | $-100.1M | $-133.5M | $-361.1M | ||
Pre-Tax Income | $-57.2M | $-49.6M | $-90.3M | $-102.0M | $-138.3M | $-366.4M | ||
INCOME TAX | ||||||||
Tax Provision | $218.0K | $-59.0K | $-147.0K | $19.0K | $3.9M | $692.0K | ||
NET INCOME | ||||||||
Net Income | $-57.4M | $-49.5M | $-90.1M | $-102.0M | $-142.2M | $-367.1M | ||
Net Income (Continuing Operations) | $-57.4M | $-49.5M | $-90.1M | $-102.0M | $-142.2M | $-367.1M | ||
Net Income (Discontinued Operations) | $-57.4M | $-49.5M | $-90.1M | $-102.0M | $-142.2M | $-367.1M | ||
Net Income (Common Stockholders) | $-57.4M | $-49.5M | $-90.1M | $-102.0M | $-142.2M | $-367.1M | ||
Normalized Income | -- | -- | -- | -- | -- | $-362.7M | ||
TOTALS | ||||||||
Total Expenses | $26.6M | $49.4M | $89.7M | $102.2M | $151.2M | $384.7M | ||
SHARE & EPS DATA | ||||||||
Average Shares Outstanding | $2.3M | $16.1M | $20.1M | $34.8M | $71.2M | $104.7M | ||
Average Shares Outstanding (Diluted) | $2.3M | $16.1M | $20.1M | $34.8M | $71.2M | $104.7M | ||
Shares Outstanding | $13.8M | $19.9M | $20.4M | $52.2M | $93.5M | $146.0M | ||
Basic EPS | -- | $-3.08 | $-4.48 | $-2.93 | $-2 | $-3.51 | ||
Basic EPS (Continuing Operations) | -- | $-3.08 | $-4.48 | $-2.93 | $-2 | $-3.51 | ||
Diluted EPS | $24.49 | $-3.08 | $-4.48 | $-2.93 | $-2 | $-3.51 | ||
Diluted EPS (Continuing Operations) | $24.49 | -- | -- | $-2.93 | $-2 | $-3.51 | ||
OTHER METRICS | ||||||||
Other Gand A | $5.3M | $13.2M | $19.4M | $21.5M | $29.0M | $39.6M | ||
Rent And Landing Fees | $-159.0K | $273.0K | $300.0K | $200.0K | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | ETNB | $14.87 | 0% | 14.37M |
3 | ||||
4 | ||||
5 | ||||
6 |